production

Photo

Containment Solutions for HPAPI Manufacturing

Clear incentive for drug manufacturers to equip their production facilities with the capacity to process highly potent active pharmaceutical ingredients (HPAPIs). HPAPIs now account for 25% of all drugs produced globally, with some analysts projecting that it will reach a value of $40 billion by 2027.

Photo

Peter Greven Starts Up New Production Facility for Ester Lubricants

Peter Greven, a leading producer of oleochemical additives with sites in Germany, the Netherlands and Malaysia, is starting up a new production facility for ester lubricants at its headquarters in Bad Münstereifel in summer 2013 - exactly 90 years after the foundation of the site.

64 more articles

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.